These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain. Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021 [TBL] [Abstract][Full Text] [Related]
3. Latest update on the Ro/SS-A autoantibody system. Schulte-Pelkum J; Fritzler M; Mahler M Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201 [TBL] [Abstract][Full Text] [Related]
4. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases. Murng SHK; Thomas M J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326 [TBL] [Abstract][Full Text] [Related]
5. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block. Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190 [TBL] [Abstract][Full Text] [Related]
6. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166 [TBL] [Abstract][Full Text] [Related]
7. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer. González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases. Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D Front Immunol; 2019; 10():444. PubMed ID: 30915082 [TBL] [Abstract][Full Text] [Related]
16. Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study. Vázquez-Del Mercado M; Martínez-García EA; Daneri-Navarro A; Gómez-Bañuelos E; Martín-Márquez BT; Pizano-Martínez O; Wilson-Manríquez EA; Corona-Sánchez EG; Chavarria-Avila E; Sandoval-García F; Satoh M Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):328-333. PubMed ID: 33876712 [TBL] [Abstract][Full Text] [Related]
17. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation. Bettacchioli E; Saraux A; Tison A; Cornec D; Dueymes M; Foulquier N; Hillion S; Roguedas-Contios AM; Benyoussef AA; Alarcon-Riquelme ME; Pers JO; Devauchelle-Pensec V; Arthritis Rheumatol; 2024 May; 76(5):751-762. PubMed ID: 38130019 [TBL] [Abstract][Full Text] [Related]
18. Strong Association of the Myriad Discrete Speckled Nuclear Pattern With Anti-SS-A/Ro60 Antibodies: Consensus Experience of Four International Expert Centers. Röber N; Dellavance A; Ingénito F; Reimer ML; Carballo OG; Conrad K; Chan EKL; Andrade LEC Front Immunol; 2021; 12():730102. PubMed ID: 34675922 [TBL] [Abstract][Full Text] [Related]
19. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies. Staikou EV; Routsias JG; Makri AA; Terzoglou A; Sakarellos-Daitsiotis M; Sakarellos C; Panayotou G; Moutsopoulos HM; Tzioufas AG Clin Exp Immunol; 2003 Oct; 134(1):143-50. PubMed ID: 12974767 [TBL] [Abstract][Full Text] [Related]
20. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome. Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]